Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$0.82 USD
0.00 (-0.09%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $0.83 +0.01 (1.31%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Vor Biopharma Inc. [VOR]
Reports for Purchase
Showing records 1 - 20 ( 50 total )
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Where the Brook Is Deep; State of Acute Myeloid Leukemia Treatment
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Trem-cel Advances in AML and Expands to MDS; Additional Data 2H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE- ASGCT 2024 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Initial Readout of VCAR33ALLO and VOR33 Update Expected in 2H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Successful Neutrophil Engraftment Continues; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Awaiting Expanded Data Sets at ASH 2023; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Trem-Cel?s Good Defense Make a Better Offense with Mylotarg
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
Trem-cel Trounces AML while Tag Team Partner Joins the Fray
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Vor Biopharma Inc.
Industry: Medical - Biomedical and Genetics
ASH 2023 Abstract Round Up for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D